https://www.thebodypro.com/article/top-tsepamo-neural-tube-defects-dolutegravir
Pregnancy, Childbirth, and HIVFeatures

Tsepamo Study Provides Critical Update on Neural Tube Defects and Dolutegravir

#4 in TheBodyPro's Top 10 HIV Clinical Developments of 2019

Dolutegravir and Pregnancy photo illo
Photo illustration: Remedy Health Media; Background and paper tear: iStock

    Original Tsepamo results: 9th IAS Conference on HIV Science. (2017). "Dolutegravir / tenofovir / emtricitabine (DTG/TDF/FTC) started in pregnancy is as safe as efavirenz / tenofovir / emtricitabine (EFV/TDF/FTC) in nationwide birth outcomes surveillance in Botswana." programme.ias2017.org/Abstract/Abstract/5532

    Expanded Tsepamo results: 10th IAS Conference on HIV Science. (2019). "Neural tube defects by antiretroviral and HIV exposure in the Tsepamo Study, Botswana." programme.ias2019.org/Abstract/Abstract/4822

    David Alain Wohl, M.D.

    David Alain Wohl, M.D.

    David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.